These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia. Liu ES; Burian C; Miller WE; Saven A Br J Haematol; 1998 Dec; 103(3):690-5. PubMed ID: 9858218 [TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816 [TBL] [Abstract][Full Text] [Related]
11. Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids. Orvain C; Ducancelle A; Eymerit-Morin C; Rousselet MC; Oberti F; Hunault-Berger M; Tanguy-Schmidt A J Clin Virol; 2015 Jan; 62():66-8. PubMed ID: 25542474 [TBL] [Abstract][Full Text] [Related]
12. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia. Hellmann A; Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Robak T Eur J Haematol; 1999 Jul; 63(1):35-41. PubMed ID: 10414453 [TBL] [Abstract][Full Text] [Related]
13. Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia. Fleischman RA; Croy D Am J Hematol; 1995 Apr; 48(4):293. PubMed ID: 7717386 [No Abstract] [Full Text] [Related]
14. Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK). Betticher DC; Hsu Schmitz SF; Ratschiller D; von Rohr A; Egger T; Pugin P; Stalder M; Hess U; Fey MF; Cerny T Br J Haematol; 1997 Nov; 99(2):358-63. PubMed ID: 9375754 [TBL] [Abstract][Full Text] [Related]
15. 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis. Zaucha JM; Hałaburda K; Ciepłuch H; Hellmann A Acta Haematol Pol; 1994; 25(2):119-27. PubMed ID: 7915075 [TBL] [Abstract][Full Text] [Related]
16. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856 [TBL] [Abstract][Full Text] [Related]
17. Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. Lewandowski K; Halaburda K; Hellmann A Leuk Lymphoma; 2002 Feb; 43(2):361-3. PubMed ID: 11999570 [TBL] [Abstract][Full Text] [Related]
18. Secondary neoplasms in two patients treated with purine analogues. Schlaifer D; Riga-Huguet F; Pris J; Brousset P; Delannoy A; Bosly A Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):341. PubMed ID: 7971258 [No Abstract] [Full Text] [Related]
19. Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine. Niesvizky R; Zhu AX; Louie D; Michaeli J N Engl J Med; 1999 Jul; 341(1):55. PubMed ID: 10391760 [No Abstract] [Full Text] [Related]
20. Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA). Chasty RC; Myint H; Oscier DG; Orchard JA; Bussutil DP; Hamon MD; Prentice AG; Copplestone JA Leuk Lymphoma; 1998 Apr; 29(3-4):391-8. PubMed ID: 9684936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]